Recommendation Statement Brief Evidence UpdateRelease Date: May 2004
Summary of Recommendation / Supporting Documents
Rating: D Recommendation.
Rationale: The USPSTF found fair evidence that screening with serum CA-125 level or transvaginal ultrasound can detect ovarian cancer at an earlier stage than it can be detected in the absence of screening; however, the USPSTF found fair evidence that earlier detection would likely have a small effect, at best, on mortality from ovarian cancer. Because of the low prevalence of ovarian cancer and the invasive nature of diagnostic testing after a positive screening test, there is fair evidence that screening could likely lead to important harms. The USPSTF concluded that the potential harms outweigh the potential benefits.
Screening for Ovarian Cancer, May 2004
Recommendation Statement
Brief Evidence Update
Return to Quick Menu: Topic Index
Return to USPSTF Home Page